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Retinal pigment epithelial cellsHypercholesterolemia and polymorphisms in the cholesterol exporter ABCA1 are linked to age-related macular
degeneration (AMD). Excessive iron in retina also has a link to AMD pathogenesis. Whether these ﬁndings mean
a biological/molecular connection between iron and cholesterol is not known. Here we examined the relationship
between retinal iron and cholesterol using a mouse model (Hfe−/−) of hemochromatosis, a genetic disorder of
iron overload.We compared the expression of the cholesterol efﬂux transporters ABCA1 andABCG1 and cholesterol
content in wild type and Hfe−/−mouse retinas. We also investigated the expression of Bdh2, the rate-limiting
enzyme in the synthesis of the endogenous siderophore 2,5-dihydroxybenzoic acid (2,5-DHBA) in wild type and
Hfe−/− mouse retinas, and the inﬂuence of this siderophore on ABCA1/ABCG1 expression in retinal pigment
epithelium. We found that ABCA1 and ABCG1 were expressed in all retinal cell types, and that their expression
was decreased in Hfe−/− retina. This was accompanied with an increase in retinal cholesterol content. Bdh2 was
also expressed in all retinal cell types, and its expression was decreased in hemochromatosis. In ARPE-19 cells,
2,5-DHBA increased ABCA1/ABCG1 expression and decreased cholesterol content. This was not due to depletion
of free iron because 2,5-DHBA (a siderophore) and deferiprone (an iron chelator) had opposite effects on transferrin
receptor expression and ferritin levels. We conclude that iron is a regulator of cholesterol homeostasis in retina and
that removal of cholesterol from retinal cells is impaired in hemochromatosis. Since excessive cholesterol is
pro-inﬂammatory, hemochromatosis might promote retinal inﬂammation via cholesterol in AMD.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
There is an overwhelming evidence for the involvement of oxidative
stress and inﬂammation in the pathogenesis of age-related macular de-
generation (AMD), a leading cause of blindness in adults in developed
countries [1–4]. There are two forms of AMD, dry and wet, the former
with accumulation of drusen deposits underneath the basal side of the
retinal pigment epithelium and the latter with abnormal development
of new blood vessels, which invade into the retina through the
Bruch's membrane. There is no consensus on whether or not a similar
mechanism participates in the pathogenesis of both forms, but theA1, ATP-binding cassette trans-
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ights reserved.involvement of oxidative stress and inﬂammation has been implicated
in dry as well as wet AMD. Accordingly, most of the animal models of
AMD are based either on disruption of inﬂammatory pathways such
as the complement system or chemokine signaling or on oxidative
damage [5].
Iron is essential for the survival of all cells, but excessive iron is
detrimental because free iron generates potent reactive oxygen species
such as hydroxyl radicals. Numerous studies have suggested a role for
excessive accumulation of iron in the retina as an important contributor
to the pathogenesis of AMD [6–8]. Retina expressesmost of the proteins
that are known to participate in the regulation of iron homeostasis, a
feature obligatory for maintenance of iron levels optimal for cellular
function without the risk of oxidative stress [9]. Disruptions in the
expression and function of these iron-regulatory proteins alter iron levels
in the retina, involving all retinal cell types. Hemochromatosis is a hered-
itary disorder caused by loss-of-functionmutations inﬁve different genes
coding for iron-regulatory proteins, namely HFE, hemojuvelin (also called
HFE2), hepcidin (also called HAMP), ferroportin, and transferrin receptor 2
(TfR2) [10–13]. This disorder represents one of themost prevalent genet-
ic diseases in humans, with homozygosity or compound heterozygosity
accounting for 1 in 300 in the general population. Mutations in HFE are
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arising from mutations in the other four genes. Irrespective of the
gene involved, hemochromatosis is associatedwith excessive iron accu-
mulation in multiple systemic organs, leading to oxidative stress and
consequent organ dysfunction. It was believed for a long time that
the retina and the brain are spared in this disease because of the
blood-retinal barrier or blood–brain barrier, but emerging evidence
strongly indicates otherwise [9,14]. Mousemodels of hemochromatosis
(Hfe−/−, Hjv−/−, and hepcidin−/−mice) have provided unequivocal ev-
idence for excessive iron accumulation in the retina in this disease
[15–17]. These mice exhibit morphological and biological changes in
the retina that are similar to those found in AMD [15–17], indicating
that iron-mediated oxidative stress is likely to be a critical determinant
in the pathogenesis and/or progression of AMD.
With regard to the role of inﬂammation in AMD, available evidence
points to the involvement of diverse immune cell types, cytokines, and
signaling pathways [3,4]. Cholesterol is receiving increasing attention
in recent years as a critical determinant of inﬂammatory pathways
[18–20], and two transporters, ABCA1 and ABCG1, both participating
in the efﬂux of cholesterol from peripheral tissues to load it to on HDL,
have been implicated in this process [21,22]. Furthermore, there is
strong evidence from animal models of hypercholesterolemia for
excessive cholesterol build-up in the retina as a causative factor in
AMD [23–26].
From what has been described above, it is likely that excessive iron
in retina may contribute to the pathogenesis/progression of AMD
through oxidative damage and that excessive cholesterol in retina
may also contribute to the pathogenesis/progression of AMD through
inﬂammation. However, whether there is any link between iron and
cholesterol in health and disease is not known. The purpose of the
present study was to investigate the expression of the cholesterol efﬂux
transporters ABCA1 and ABCG1 in the retina in normal mice and in a
mouse model of hemochromatosis (Hfe−/−mouse) and also to deter-
mine how the iron status in retina and RPE inﬂuences the expression
of these two transporters. Furthermore, there has been a recent devel-
opment in the area of iron homeostasis in mammalian cells, which in-
volves identiﬁcation of an endogenous siderophore (i.e., iron carrier)
and the enzyme critical for its synthesis [27]. The siderophore is
2,5-dihydroxybenzoic acid (2,5-DHBA) and the enzyme is the cytosolic
β-hydroxybutyrate dehydrogenase, known as Bdh2. This siderophore
binds iron and facilitates its entry through plasma membrane and
mitochondrial inner membrane [27]. There is no information available
at present on the expression of Bdh2 and on the role, if any, of the
newly discovered endogenous siderophore in the retina; therefore,
here we studied the expression of this important iron-regulatory
enzyme in the retina in wild type and Hfe−/−mice and also examined
the inﬂuence of the siderophore 2,5-DHBA on the expression of
ABCA1 and ABCG1 in RPE cells.2. Materials and methods
2.1. Materials
Antibodies were obtained from the following sources: rabbit poly-
clonal anti-ABCA1 and rabbit polyclonal anti-ABCG1 (Novus Biologicals,
Littleton, CO, USA), goat polyclonal anti-Bdh2 (Abcam, Cambridge, MA,
USA), mouse monoclonal anti-vimentin (Millipore, Billerica, MA, USA)
and chicken anti-MCT1 (Alpha Diagnostic International, San Antonio,
TX, USA), goat anti-rabbit IgG coupled to Alexa Fluor 568, donkey
anti-goat IgG coupled to Alexa Fluor 568, goat anti-chicken IgG coupled
to Alexa Fluor 568, and goat anti-rabbit and anti-mouse IgG coupled to
Alexa Fluor 488 (Molecular Probes, Carlsbad, CA, USA). The dilutions of
the antibodies used for immunoﬂuorescence experimentswere: 1:1000
for ABCA1, 1:25 for ABCG1, 1:50 for vimentin, 1:50 for Bdh2, and 1:1000
for MCT1. Rabbit polyclonal antibodies speciﬁc for L-ferritin andH-ferritin were provided by Professor P. Arosio (Dipartimento Materno
Infantile e Tecnologie Biomediche, Universita di Brescia, Brescia, Italy).
2.2. Animals
Breeding pairs of Hfe+/− mice were obtained from the Jackson
Laboratory (Bar Harbor, ME, USA). Age- and gender-matched wild
type and Hfe−/− mice were obtained from the same litter originating
from the mating of heterozygous mice. Albino Balb/c mice (6-week-
old) were used for immunoﬂuorescence analyses in some studies.
Mice were purchased from Harlan–Sprague Dawley, Inc. (Indianapolis,
IN, USA). All experimental procedures involving these animals adhered
to the “Principles of Laboratory Animal Care” (National Institutes of
Health publication #85-23, revised in 1985) and were approved by
the Institutional Committee for Animal Use in Research and Education.
2.3. Immunoﬂuorescence analysis
Eyes were embedded in OCT compound and frozen at –20 °C. Sec-
tions (8-μm thick) were used for immunostaining by ﬁxing in 4% para-
formaldehyde for 10 min, washed with 0.01 M phosphate-buffered
saline (pH 7.4), and blocked with 1× Power Block for 60 min. Sections
were then incubated overnight at 4 °C with appropriate primary anti-
bodies. Negative controls involved omission of the primary antibodies.
Sections were rinsed and incubated for 1 h with appropriate secondary
antibodies. Coverslips weremounted after stainingwith Hoechst nucle-
ar stain and sections were examined by epiﬂuorescence microscopy
(Axioplan-2 microscope, equipped with an HRM camera and the Axio-
Vision imaging program; Carl Zeiss, Jena, Germany).
2.4. Primary RPE, Müller, and ganglion cell cultures from mouse eyes
Primary cultures of RPE were prepared as described previously
[15,17]. Three-week-oldwild type andHfe−/−micewere used to estab-
lish primary cultures of RPE. The purity of the culture was veriﬁed by
immunodetection of RPE-65 (retinal pigment epithelial protein 65)
and CRALBP (cellular retinaldehyde binding protein). Müller cells
were prepared from 7- to 10-day-old C57BL/6 mice by a method
adapted fromHicks and Courtois [28] and described in one of our previ-
ous publications [29]. Staining for the Müller cell markers glutamine
synthetase, glutamate transporter EAAT1, and CRALBP conﬁrmed the
purity of the primary cultures. Retinal ganglion cells were isolated by
immunopanning from 2-day-old C57BL/6 mice by themethod of Barres
et al. [30] as described previously in our publications [31,32]. The purity
of the cultures was conﬁrmed by immunostaining for Thy-1, a ganglion
cell marker.
2.5. Real time PCR
The following real time primers were used: 5′-AGTTTCGGTATGGC
GGGTTT-3′ (forward) and 5′-AGCATGCCAGCCCTTGTTAT-3′ (reverse)
for mouse ABCA1; 5′-ACCTACCACAACCCAGCAGACTTT-3′ (forward)
and 5′-GGTGCCAAAGAAACGGGTTCACAT-3′ (reverse) for mouse
ABCG1; 5′-GATGCAACTGTGTGTGTCCAGGAA-3′ (forward) and 5′-
ACAGGGTTGCCAGTTACATAGGCT-3′ (reverse) for mouse Bdh2; 5′-
GAAGTACATCAGAACATGGGC-3′ (forward) and 5′-GATCAAAGCCATGG
CTGTAG-3′ (reverse) for human ABCA1; 5′-CAGGAAGATTAGACACTG
TGG-3′ (forward) and 5′-GAAAGGGGAATGGAGAGAAG-3′ (reverse)
for human ABCG1; 5″-GAGGACGCGCTAGTGTTCTT-3′ (forward) and
5′-TGTGACATTGGCCTTTGTGTT-3′ (reverse) for human transferrin re-
ceptor 1 (TfR1). 18S and hypoxanthine phosphoribosyl transferase 1
(HPRT1) were used as internal controls. Real-time ampliﬁcations
using SYBR Green detection chemistry were run in triplicate on 96-
well reaction plates. Reactions were prepared in a total volume of
25 μl containing: 5 μl cDNA, 0.5 μl of each 20 μM primer, 12.5 μl of
SYBR® Green Supermix and 6.5 μl RNase/DNase-free sterile water.
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ditions were set as follows: initial template denaturation at 95 °C for
1 min, followed by 40 cycles of denaturation at 95 °C for 10 s, and com-
bined primer annealing/elongation at 60 °C for 30 s and 70 °C for 45 s.
This cycle was followed by a melting curve analysis, ranging from
56 °C to 95 °C, with temperature increasing by steps of 0.5 °C every
10 s. Baseline and threshold values were automatically determined for
all plates using the StepOne software. Raw Ct values were transformed
to quantities using an Excel spreadsheet. The resulting data were con-
verted into correct input ﬁles, according to the requirements of the soft-
ware, and analyzed for fold change using the Excel spreadsheet.
RNA isolated fromwhole retinawas used for qPCR. Mice were killed
by cervical dislocation under isoﬂurane anesthesia and the eyes were
removed. Extraocular tissues connected to the eyeball were removed
with scissors, and then a small cut was made on the anterior side of
the eyeball to remove the lens and the vitreous. The remaining
part consisting of the neural retina, RPE, and choroid was used for
preparation of RNA.2.6. Treatment of primary RPE cells with 5-azacytidine
Wild type andHfe−/− primary RPE cells were seeded in 6well plates
and treated with the DNA-demethylating agent, 5-azacytidine (5-AzaC;
2 μg/ml) for 24 h. RNA was isolated from the cells for real-time PCR.2.7. Analysis of ABCG1 and ABCG1 expression in control and DNMT1−/−,
DNMT3b−/−, and DNMT1−/−/DNMT3b−/− cancer cells
Control HCT116 cells, a human colon cancer cell line, and isogenic
HCT116 cells with deletion of DNMT1 (DNMT1−/−), DNMT3b
(DNMT3b−/−), or both (double-knockout or DKO) were originally pro-
vided by Dr. Bert Vogelstein (Johns Hopkins University, Baltimore,
MD, USA). RNA prepared from these cells was used for RT-PCR to deter-
mine the role of DNMT1 and DNMT3b in the control of expression of
ABCA1 and ABCG1.2.8. Quantiﬁcation of cholesterol levels
The levels of total cholesterol in retinal tissue and ARPE-19 cells
were measured using a commercially available assay kit (Cell Biolabs,
Inc., San Diego, CA, USA). This is a ﬂuorometric assay, which involves
the extraction of total cholesterol with chloroform/isopropanol/NP-40.
In the case of retinal tissue, lens and vitreous were removed from the
eye and the rest of the tissue was used for the assay. The data are
presented μM in the tissue/cell extracts; based on the volumes of the
tissue extracts that were used in the technique, 1 μM equals 0.8 nmol
of cholesterol/retina and 0.67 nmol/mg of protein for ARPE-19 cells.2.9. Inﬂuence of 2,5-DHBA (a siderophore) and deferiprone (an iron
chelator) on TfR1 mRNA levels and ferritin protein levels
ARPE-19 cells were cultured in 6-well culture dishes for two days
and then treated with 2,5-DHBA (250 μM) or deferiprone (250 μM)
for 16 h and then the cells were used for preparation of RNA and protein
extracts. Untreated cells were used as the control. Steady-state levels of
TfR1mRNAweremonitored by RT-PCR and qPCR. To determine the fer-
ritin levels, protein was extracted from the cells using the lysis buffer
(10 mM Tris/HCl buffer, pH 7.6, 50 mM NaCl, 1% Triton X-100, 5 mM
ethylenediamine tetraacetate) containing a cocktail of protease and
phosphatase inhibitors (Thermo Scientiﬁc, Waltham, MA, USA). The
levels of ferritin (heavy chain H aswell as light chain L)weremonitored
by Western blot using speciﬁc antibodies. β-Actin was used as the
internal control for protein loading in Western blot analysis.2.10. Statistics
Statistical differenceswere calculated by paired Student's t test or by
ANOVA as appropriate. A p b 0.05 was considered as statistically
signiﬁcant.
3. Results
3.1. Expression of ABCA1 and ABCG1 in mouse retina and their polarized
distribution in RPE
We examined the expression of ABCA1 and ABCG1 in mouse retina
by immunoﬂuorescence analysis. We used the albino Balb/c mice for
this purpose because the lack of pigment in RPEmakes it easy to visual-
ize the polarized distribution of proteins in the basolateral membrane
versus apical membrane. Both transporters were robustly expressed in
the retina with almost a similar expression pattern (Fig. 1A). The pro-
teins were detectable in all cell layers of the retina, including the RPE.
In photoreceptor cells, ABCA1 was detected in the inner segment and
ABCG1 in the outer segment. Since RPE is a polarized cell, we examined
by confocal microscopy the expression of ABCA1 and ABCG1 in the two
poles of the RPE plasma membrane, the apical membrane, which faces
the subretinal space and the basolateral membrane, which faces
the choroid. We used double-labeling for this purpose with MCT1
(monocarboxylate transporter 1) as the marker for the RPE cell apical
membrane [33]. We have used this marker successfully in many of our
previously published studies to determine the polarized expression of
several transporters and receptors [34–37]. We found ABCA1 as well
as ABCG1 to colocalize with MCT1, indicating the presence of both
transporters in the apical membrane (Fig. 1B). The basal membrane
also was immunopositive for both transporters, but the protein levels
in the apical membraneweremuch higher than in the basalmembrane.
We conﬁrmed the expression of ABCA1 and ABCG1 in primary mouse
retinal ganglion cells, Muller cells, and RPE cells by real-time RT-PCR
(Fig. 1C). ABCA1 expression was much higher in pRPE and pMC than
in pGC; in contrast, ABCG1 expression was much higher in pRPE than
in pMC and pGC.
3.2. Downregulation of ABCA1 and ABCG1 in hemochromatosis retina
We then compared the expression of both transporters between
wild type mouse retina and Hfe−/−mouse retina. We used 18-month-
old mice for these experiments because of our earlier ﬁndings that ret-
inal degeneration becomes evident in Hfe−/− mice only at ages older
than 1 year [15]. We found the expression of ABCA1 and ABCG1 to be
decreased in Hfe−/− mouse retinas (Fig. 2). The decrease was evident
in all cell layers of the retina. This phenomenon was conﬁrmed by cor-
responding changes in steady-state mRNA levels for both transporters
in whole retina (Fig. 3A).
3.3. Involvement of DNA methylation in the suppression of ABCA1 and
ABCG1 expression in Hfe−/−mouse retina
There is evidence for the regulation of ABCA1 expression by promot-
er methylation [38,39]; hypermethylation of ABCA1 in the promoter
region silences the gene expression. We have shown recently that the
levels of DNA methyltransferases are elevated in Hfe−/− mouse RPE
cells [40]. These ﬁndings led us to hypothesize that the suppression of
ABCA1 and ABCG1 observed in Hfe−/− retinas may occur epigenetically
through DNA methylation. We tested this hypothesis by studying the
inﬂuence of the DNA methylation inhibitor 5′-azacytidine on the
steady-state levels of mRNA for ABCA1 and ABCG1 in pRPE cells
prepared fromwild type and Hfe−/−mouse retinas. Without any treat-
ment, the levels of ABCA1 and ABCG1 expression were signiﬁcantly
lower in RPE cells from Hfe−/− mice than in RPE cells from wild type
mice (Fig. 3B). Treatment of wild type RPE cells with the DNA
Fig. 1.Expression of ABCA1 andABCG1 inmouse retina. (A) The expression of ABCA1 andABCG1 inmouse (Balb/c) frozen retinal sectionswas studied by immunoﬂuorescence. Red signals
indicate the protein expression and blue signals indicate nuclei. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. (B) The
polarized expression of ABCA1 and ABCG1 in RPE cell apical membrane versus basolateral membrane was studied by double-labeling immunoﬂuorescence using MCT1 as a marker for
RPE cell apical membrane. Green, ABCA1 or ABCG1; red, MCT1; blue, nuclei. (C) Relative levels of ABCA1 and ABCG1 mRNAs in primary cultures of mouse retinal pigment epithelial
cells (pRPE), Muller cells (pMC), and ganglion cells (pGC) as assessed by real-time RT-PCR. The mRNA level in pRPE was taken as 1.
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sion of both transporters whereas under similar conditions the DNA
methylation inhibitor increased the expression of both transporters in
Hfe−/− RPE cells (Fig. 3B). In fact, the decrease inmRNA levels observed
in Hfe−/− RPE cells compared to wild type RPE cells disappeared after
treatmentwith 5′-azacytidine, suggesting thatDNAmethylationwas al-
most entirely responsible for the hemochromatosis-associated decrease
in the retinal expression of ABCA1 andABCG1. To determine the identity
of DNMT isoform that was responsible for this phenomenon, we used a
human colon cancer cell line (HCT116), which is available with and
without DNMT1, DNMT3b, or both. These are isogenic cell lines, the
only difference being the presence or absence of speciﬁc DNMT iso-
forms.We found the expression of ABCA1 andABCG1 to bemarkedly in-
creased in DNMT1−/−/DNMT3b−/− double-knockout cells (data not
shown), suggesting that the hemochromatosis-associated silencing of
the cholesterol efﬂux transporters may similarly require DNMT1 or
DNMT3b.3.4. Retinal and RPE cholesterol levels in wild type and Hfe−/−mice
The function of ABCA1 and ABCG1 is to remove cholesterol from the
cells by an active mechanism coupled to ATP hydrolysis. Therefore, the
decreased expression of these two transporters in hemochromatosis
mouse retina should be associated with increased cholesterol levels.
This was indeed the case. The levels of cholesterol in whole retina
were signiﬁcantly higher in Hfe−/− mice than in wild type mice
(Fig. 4A). This phenomenon was also observed in the primary cultures
of RPE cells prepared from wild type mice and Hfe−/−mice (Fig. 4B).3.5. Effect of the mammalian siderophore 2,5-DHBA on the expression of
ABCA1 and ABCG1 in RPE
It has recently been shown that mammalian cells synthesize an
endogenous siderophore (i.e., an iron carrier), known as 2,5-
dihydroxybenzoic acid (2,5-DHBA), which facilitates the transfer of
iron across the plasmamembrane aswell as across the innermitochon-
drial membrane [27]. Since the expression of ABCA1 and ABCG1 in the
retina is altered in the iron-overload disease hemochromatosis, we
wondered whether treatment of RPE cells with the endogenous
siderophore would have any effect on the expression of these trans-
porters. To address this issue, we treated the human RPE cell line
ARPE-19, a widely used model for RPE [41], with 2,5-DHBA for 16 h
and then monitored the levels of ABCA1 and ABCG1 mRNAs. These ex-
periments showed that the expression of both transporters was upreg-
ulated signiﬁcantly in the RPE cell line when treated with 2,5-DHBA
(Fig. 5A). This was associated with a decrease in the cellular cholesterol
content as expected from the known function of these transporters in
the efﬂux of cholesterol from the cells (Fig. 5B). Since 2,5-DHBA is not
simply an iron chelator but rather an iron carrier responsible for iron
entry into the cell and also into the mitochondria, we asked whether
the observed effects of this siderophore on the expression of the choles-
terol efﬂux transporters is due to depletion of free iron. To address this
question, we compared the inﬂuence of 2,5-DHBA with that of
deferiprone, which functions simply as an iron chelator rather than as
an iron carrier. ARPE-19 cells were treated with 250 μM of either 2,5-
DHBA or deferiprone for 16 h and then the levels of TfR1 mRNA were
measured by RT-PCR and qPCR and ferritin protein levels were mea-
sured by Western blot. Steady-state levels of TfR1 mRNA as well as H
Fig. 2. Comparison of ABCA1 and ABCG1 protein expression in the retina betweenwild type mice (HFE-WT) and Hfe−/−mice (HFE-KO). (A) Expression of ABCA1 inmouse frozen retinal
sectionswas studied by immunoﬂuorescence. Red signals indicate ABCA1 protein and blue signals indicate nuclei. (B) Expression of ABCG1 inmouse frozen retinal sectionswas studied by
immunoﬂuorescence. Red signals indicate ABCG1 protein and blue signals indicate nuclei. In both cases, age-matched (18-month-old) wild type and Hfe−/−mice were used for prepara-
tion of retinal sections.
Fig. 3. ABCA1 and ABCG1mRNA levels inwild type andHfe−/−mouse retinas and the role of DNAmethylation on the expression of ABCA1 and ABCG1 in RPE. (A)mRNA levels for ABCA1
andABCG1were compared betweenwild type (HFE-WT) andHfe−/− (HFE-KO)mouse retinas by real-time RT-PCR. *,p b 0.05 compared toHFE-WTbypaired Student's t test. (B) Inﬂuence
of DNA methylation on ABCA1 and ABCG1 expression in primary cultures of RPE cells. Cells prepared from wild type and Hfe−/−mice were subjected to treatment with and without
5′-azacytidine (2 μg/ml) in the culture medium for 24 h. Following the treatment, RNA was prepared and used for real-time RT-PCR to quantify the levels of ABAC1 and ABCG1
mRNAs. *, p b 0.05 as assessed by ANOVA.
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Fig. 4. Retinal and RPE cholesterol levels in wild type (HFE-WT) and Hfe−/− (HFE-KO)
mice. (A) Age-matched (18-month-old) wild type and Hfe−/−mouse retinas were used
for measurement of cholesterol. **, p b 0.01 compared to wild type control by paired
Student's t test. (B) Cholesterol content in primary cultures of RPE cells prepared from wild
type and Hfe−/−mice. **, p b 0.01 compared to wild type control by paired Student's t test.
Fig. 6. Inﬂuence of 2,5-DHBA (a siderophore) and deferiprone (an iron chelator) on the
levels of TfR1 mRNA and ferritin protein (heavy chain H and light chain L) in RPE. The
human RPE cell line ARPE-19 was exposed to 250 μM of either 2,5-DHBA or deferiprone
for 16 h and then total RNA was isolated and protein extracts prepared. Untreated cells
608 S. Ananth et al. / Biochimica et Biophysica Acta 1842 (2014) 603–612subunit of ferritin were decreased with 2,5-DHBA (Fig. 6). These data
were unexpected; while the changes in H-ferritin suggest depletion of
free iron, the changes in TfR1 mRNA suggest the opposite. This was in
contrast with the ﬁndings that treatment of the cells with deferiprone
increased the levels of TfR1 mRNA and decreased the levels of
H-ferritin,which indicate that deferiprone does indeed deplete intracel-
lular levels of free iron under similar conditions as expected of an iron
chelator.were used as the control. The changes in the steady-state levels of TfR1 mRNAwere mon-
itored by RT-PCR and qPCR (A & B) and those in ferritin (heavy chain H and light chain L)
were monitored by Western blot (C).3.6. Expression pattern of Bdh2, the enzyme critical for the biosynthesis of
2,5-DHBA, in the retina
The enzyme that is critical for the synthesis of 2,5-DHBA inmamma-
lian cells is β-hydroxybutyrate dehydrogenase-2 (Bdh2) [27]. We
examined the expression pattern of this enzyme in mouse retina. We
found robust expression of the enzyme throughout the retina in allFig. 5. Inﬂuence of the endogenous iron chelator 2,5-dihydroxybenzoic acid (2,5-DHBA) on th
were treatedwith 250 μM2,5-DHBA for 24 h and the levels of ABCA1 and ABCG1mRNAswere t
Student's t test. (B) The cells were treatedwith 250 μM2,5-DHBA for 24 h and the cellular levels
test.cell layers, including ganglion cells, Muller cells, and RPE cells (Fig. 7).
The radial distribution pattern of the immune-positive signals in the ret-
inal sections indicated the expression of the enzyme inMuller cells. This
was conﬁrmed by double-labeling with vimentin, a marker for retinal
Muller cells.WeusedRNA isolated fromprimarymouse retinal ganglione expression of ABCA1 and ABCG1 and cholesterol content in ARPE-19 cells. (A) The cells
hen determined by real-time RT-PCR. *, p b 0.05; **, p b 0.01 compared to control by paired
of cholesterolwere then determined. **, p b 0.01 compared to control by paired Student's t
Fig. 7. Expression pattern of Bdh2 in mouse retina. Mouse (Balb/c) frozen retinal sections were used for immunoﬂuorescence to determine the expression pattern of Bdh2 (red ﬂuores-
cence signals). Vimentin (green ﬂuorescence signals) was used as a marker for Muller cells and Hoechst stain (blue ﬂuorescence signals) for nuclei. GCL, ganglion cell layer; INL, inner
nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium.
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levels of this enzyme in the three retinal cell types (Figs. 8A, B). The
expression in RPE was maximal, followed by Muller cells and then
ganglion cells.
3.7. Regulation of Bdh2 expression in the retina in hemochromatosis
Since 2,5-DHBA as a siderophore is a critical component of iron
homeostasis in mammalian cells, we wondered whether the synthesis
of this compound is altered in the iron-overload disease hemochroma-
tosis. To address this issue, we examined the expression of Bdh2 in
wild type mouse retina and Hfe−/− mouse retina. We found marked
reduction in Bdh2 mRNA levels in hemochromatosis retinas compared
to wild type retinas (Fig. 8C). This was also evident at the protein level
(Fig. 9). The decrease in Bdh2 expression observed in Hfe−/− mouse
retina was evident in all cell layers.
4. Discussion
Themost salient ﬁndings of the present study can be summarized as
follows: (a) the cholesterol efﬂux transporters ABCA1 and ABCG1 are
expressed in three important cell types in the retina, namely the
ganglion cells, Muller cells, and RPE cells; (b) the expression of both
transporters is downregulated to a signiﬁcant extent in the iron-
overload disease hemochromatosis, and the decrease in the expression
is evident in all three cell types (RPE, Muller cells, and ganglion cells);
(c) the disease-associated silencing of ABCA1 and ABCG1 in the retinaFig. 8. Relative expression of Bdh2 in primary cultures of mouse retinal ganglion cells, Muller ce
KO)mice. (A) RT-PCR analysis of Bdh2mRNA levels in primary cultures ofmouse RPE cells (pRP
(B) Real-time RT-PCR analysis of relative levels of Bdh2 mRNA in primary cultures of mouse RP
taken as 1. (C) Comparison of Bdh2mRNA in retinas from age-matched (18-month-old)wild typ
control by paired Student's t test.occurs most likely via epigenetic mechanism involving DNA methyla-
tion; (d) the decrease in the expression of the two transporters in
hemochromatosismouse retina is associatedwith an increase in choles-
terol content in the tissue; (e) the treatment of the RPE cell lineARPE-19
with the recently discovered endogenous siderophore 2,5-DHBA en-
hances the expression of ABCA1 and ABCG1 with resultant decrease in
cellular content of cholesterol; (f) the mouse retina and several impor-
tant retinal cell types (ganglion cells, Muller cells, and RPE cells) express
Bdh2, which is the critical rate-limiting enzyme in the synthesis of
2,5-DHBA; and (g) the expression of this enzyme is downregulated in
hemochromatosis mouse retina.
The ﬁndings of this study are signiﬁcant for several reasons. These
have relevance to retinal biology both in health and disease states. Cho-
lesterol is an important component of cell membranes, not only as a
structural constituent but also as a modulator of membrane permeabil-
ity, and the state and function of microdomains such as the lipid rafts,
which are critical for the transmission of intracellular signals from vari-
ous cell-surface receptors. Therefore, it is essential to understand how
the cellular and tissue content of cholesterol are regulated in the retina.
ABCA1 and ABCG1 represent two important transporters that mediate
the ATP-coupled efﬂux of cholesterol from the cells. There is some evi-
dence in the literature for the expression of ABCA1 in the retina. Duncan
et al. [42] and Simon et al. [43] have shown that ABCA1 is expressed in
the retina and RPE cells. The study by Duncan et al. [42] has demonstrat-
ed the expression of ABCA1 protein in the inner segment of photorecep-
tor cells by immunoﬂuorescence analysis and in the basolateral
membrane of RPE cells by functional analysis. Our studies not onlylls, and RPE cells and retinal expression of Bdh2 in wild type (HFE-WT) and Hfe−/− (HFE-
E),Muller cells (pMC), and ganglion cells (pGC). 18SmRNAwas used as an internal control.
E cells (pRPE), Muller cells (pMC), and ganglion cells (pGC). The mRNA level in pRPE was
e andHfe−/−mice asmonitored by real-time RT-PCR. ***, p b 0.001 compared towild type
Fig. 9. Comparison of Bdh2 protein expression in the retina betweenwild type (HFE-WT) andHfe−/− (HFE-KO)mice. Bdh2 protein expressionwasmonitored in frozen retinal sections by
immunoﬂuorescence (red ﬂuorescence signals) with Hoechst stain (blue ﬂuorescence signals) to visualize nuclei. Age-matched (18-month-old) mice were used.
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the presence of ABCA1 in the apical membrane of RPE cells. The expres-
sion of ABCG1 has never been studied in the retina, and the present
study is the ﬁrst to demonstrate the expression of this cholesterol efﬂux
transporter in the retina and retinal cell types. Even though the retinal
expression pattern of the two transporters is similar for most part,
which includes expression in several important cell types (ganglion
cells, Muller cells, and RPE cells) and presence in the apical as well as
basolateral membrane of RPE cells, the two transporters differ in one
important aspect. While ABCA1 is expressed in the inner segment of
the photoreceptor cells, ABCG1 is restricted to the outer segment.
The functional signiﬁcance of ABCA1 and ABCG1 in RPE is readily
apparent, particularly the ﬁndings that the transporters are expressed
more robustly in the apical membrane than in the basolateral mem-
brane. RPE cells handle a large load of cholesterol arising from phagocy-
tosis of the outer segments of photoreceptor cells; as such, RPE cells
must possess transport mechanisms to remove cholesterol as a means
to prevent excessive accumulation of this lipid inside the cells. ABCA1
and ABCG1 are likely to serve this important role. The quantitatively
more robust expression of both transporters in the apical membrane
of RPE cells underlines the essential function of this cell in supplying
cholesterol to the neural retina. We speculate that the photoreceptor-
derived cholesterol in RPE cells following phagocytosis is not only
removed from the retina via ABCA1 and ABCG1 in the basolateral mem-
brane but is also efﬂuxed into neural retina via ABCA1 and ABCG1 in the
apical membrane for re-use by the photoreceptor cells. The supply of
cholesterol to the neural retina may not be the only function of ABCA1
and ABCG1 in the apical membrane of RPE cells. There is evidence sug-
gesting an essential role for ABCA1 in delivering the dietary lipids lutein
and zeaxanthin to the retina [44,45]. Defects in the function of this
transporter are associated with a signiﬁcant decrease in retinal levels
of these lipids. Therefore, in addition to the role in the re-circulation of
cholesterol between photoreceptor cells and RPE cells, the apically lo-
cated ABCA1 and ABCG1 in RPE cells may also function in the supply
of lutein and zeaxanthin to neural retina.
Polymorphisms in ABCA1 have been implicated in the pathogenesis
of AMD [46–49]. However, a major part of the effort to explain the link
between defective ABCA1 and AMD at the functional level has focusedon the relevance of this transporter to reverse-cholesterol transport in
mediating cholesterol efﬂux from macrophages to load it on high-
density lipoprotein (HDL). A recent study has shown that senescent
macrophages exhibit decreased expression and activity of ABCA1 and
that the resultant accumulation of cholesterol within the aged macro-
phages polarizes these cells to an abnormal phenotype that promotes
pathologic vascular proliferation [50]. Deletion of Abca1 selectively in
macrophages mimics the phenotype of senescent macrophages. In con-
trast, disruption of cholesterol homeostasis in retinal cells such as RPE as
a potential contributor to the pathogenesis of AMD has received less at-
tention. Our present studies reporting on the robustwidespread expres-
sion of the cholesterol efﬂux transporters ABCA1 and ABCG1 in the
retina are likely to form the basis for future research focusing on the
potential role of altered cholesterol homeostasis within retinal cells in
the pathogenesis of AMD. There is strong evidence supporting a patho-
genic role of excessive cholesterol in AMD [23–26]; therefore, defects in
the function of the two cholesterol efﬂux transporters examined in the
present study are expected to disrupt cholesterol homeostasis in the
retina and hence may contribute to the progression of AMD.
The present studies also report for the ﬁrst time on the association
between the genetic disease hemochromatosis and cholesterol accumu-
lation within the retina and RPE. To the best of our knowledge, there
have been no studies in the literature indicating any role for iron in
the regulation of cholesterol homeostasis. Our studies show that iron
is an important regulator of retinal cholesterol levels in health and dis-
ease. Hemochromatosis is a disease of iron overload in systemic organs
aswell as in retina. The present ﬁndings that excessive iron in the retina
in amousemodel of hemochromatosis disrupts cholesterol homeostasis
through downregulation of the cholesterol efﬂux transporters ABCA1
and ABCG1 are interesting because of the increasing evidence of the in-
volvement of excessive iron in the progression of AMD. Themechanism
underlying the decrease in ABCA1 and ABCG1 expression in hemochro-
matosis mouse retina involves DNA methylation. Even though our
previous studies showing an increase in the expression of DNAmethyl-
transferases in hemochromatosis mouse RPE cells [40] offer amolecular
mechanism for the silencing of the two cholesterol efﬂux transporters,
how excessive iron increases the expression of DNMTs is not known.
Nonetheless, the importance of the ﬁndings to retinal cholesterol
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sis is very high in general population. Interestingly, even though this is
a genetic disease, the appearance of clinical complications is age-
dependent. In patients with this disease, it takes decades for iron to
accumulate in tissues to pathogenic levels, precipitating clinical symp-
toms. This is true not only for the pathological symptoms associated
with systemic organs but also for the biochemical and morphological
changes associated with the retina. Given the similarities between the
appearance of pathological complications in hemochromatosis and
AMD in terms of age-dependence, we speculate that hemochromatosis
may contribute to the progression of AMD through excessive iron. Accu-
mulation of iron in tissues to abnormally high levels is known to cause
oxidative damage, which could be a contributing factor in the progres-
sion of AMD. The ﬁndings of the present study linking excessive iron
to disruption of cholesterol homeostasis in the retina offer an additional,
but hitherto unknown, potential molecular link between hemochroma-
tosis and AMD.
Deletion ofHfe inmice leads to signiﬁcant biochemical andmorpho-
logical alterations in the retina [15,36,37]. Some of these changes are
similar to those found in AMD. To what extent these similarities in
retinal features seen in hemochromatosis and AMD can be explained
in terms of the changes in retinal cholesterol content is not known.
The retinal pathology begins to appear in hemochromatosis mice only
at N18 months of age [15,36]. It would be interesting to determine if the
progression of the retinal pathology is accelerated in Hfe−/−/Abca1−/−
mice or Hfe−/−/Abcg1−/−mice.
Another important observation of the present study is the evidence
that the retina expresses the enzyme Bdh2 that is critical for the synthe-
sis of the endogenous siderophore 2,5-DHBA, that the expression of this
iron-regulatory enzyme is altered in the retina in the iron-overload dis-
ease hemochromatosis, and that the newly discovered siderophore 2,5-
DHBA regulates cholesterol homeostasis in RPE. The expression of the
enzyme is highest in RPE, much higher than inMuller cells and ganglion
cells. These ﬁndings suggest that RPE and other cell types in the retina
are capable of synthesizing 2,5-DHBA. Being a siderophore, this com-
pound is likely to play a critical role in the biology of iron in the retina,
particularly with regard to subcellular distribution of iron in the cyto-
plasm versus mitochondria due to the function of this compound as a
carrier of iron across the plasmamembrane and the innermitochondrial
membrane [27]. It is quite intriguing to note that so many genes have
already been identiﬁed as key players in iron homeostasis and that
loss-of-function mutations in ﬁve different genes can lead to the iron-
overload disease hemochromatosis. BDH2 represents the newest addi-
tion to the already known plethora of genes that control iron homeosta-
sis. The function of iron as a regulator of cholesterol homeostasis in RPE
is evident from the present ﬁndings that exposure of RPE cells to the en-
dogenous siderophore 2,5-DHBA inﬂuences the expression of ABCA1
and ABCG1. Interestingly, the effect of 2,5-DHBA on the steady-state
levels of TfR1 mRNA is different from that of the iron chelator
deferiprone, suggesting that the consequences of 2,5-DHBA-induced
perturbation in subcellular distribution of iron inside the cell are not
the same as those of a global decrease in intracellular levels of free
iron caused by an iron chelator. However, 2,5-DHBA and deferiprone
had similar effects on the cellular levels of H-ferritin. There is no infor-
mation in the literature as to how changes in subcellular distribution
of iron inside the cell inﬂuence TfR1 mRNA and ferritin protein levels.
The results presented here are the ﬁrst to describe the inﬂuence of the
endogenous siderophore 2,5-DHBA on TfR1 mRNA and ferritin levels.
Equally interesting is the observation that the retinal expression of
Bdh2 is downregulated in hemochromatosis. This has signiﬁcant impli-
cations in thepathology of the disease because impaired synthesis of the
endogenous siderophore is expected to decrease the delivery of iron to
the mitochondria. Since excessive iron in mitochondria is toxic to the
cell, it is likely that the downregulation of the synthesis of this
siderophore in hemochromatosis represents a compensatory mecha-
nism to blunt the toxic effects of excessive iron accumulation associatedwith the disease. A recent study has demonstrated the downregulation
of BDH2 in the liver of patients with hemochromatosis [51]. Ours is the
ﬁrst report on the expression of this enzyme in normal retina and on the
suppression of its expression in hemochromatosis, thus providing an-
other important link between hemochromatosis and retinal pathology,
particularly AMD.
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